It just broke the pivot with heavy volume. RSI is hitting the resistance. It may be back test at $4.35
biocrystbiotechnologyhealthcarenasdaqpharmaceuticalsTrend Analysisusstocks

Aussi sur:

Clause de non-responsabilité